GSK 525768A
|
|
- CAS号:
- 1260530-25-3
- 英文名:
- GSK-525768A
- 英文别名:
- GSK-525768;GSK525768A;GSK 525768A;GSK-525768A;GSK525768A; GSK-525768A;(4R)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide;4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4R)-
- 中文名:
- GSK 525768A
- 中文别名:
- 化合物 T11472;BROMODOMAIN抑制剂(GSK 525768A)
- CBNumber:
- CB22666624
- 分子式:
- C22H22ClN5O2
- 分子量:
- 423.9
- MOL File:
- 1260530-25-3.mol
|
|
|
GSK 525768A化学性质
-
熔点:
-
140-145℃
-
|
-
密度:
-
1.35±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
形态:
-
Powder
-
|
-
酸度系数(pKa):
-
15.71±0.46(Predicted)
-
|
GSK 525768A性质、用途与生产工艺
GSK 525768A 是 GSK525762A 的无活性对映体。GSK 525768A 对 BET 没有活性。
GSK 525768A has no activity towards BET. GSK 525768A (GSK525768A) is the (R)-enantiomer of GSK525762A. GSK525762A is shown to regulate levels of the high-density lipid protein apolipoprotein A1 (APOA1) in assays monitoring APOA1 release in liver cells, whereas the (R)-enantiomer (GSK 525768A) has no effect. GSK 525768A directly engages the protein module by forming hydrogen bonds with the conserved asparagine residue in a way that mimics the binding mode of acetylated lysine; this usually results in the binding of the inhibitor deeper within the acetylated lysine binding site but without displacing the conserved water molecules that are present at the bottom of the acetyl-lysine binding cavity.
GSK 525768A
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/01/25 | HY-13032A | GSK 525768A GSK 525768A | 1260530-25-3 | 2mg | 2170元 |
2024/01/25 | HY-13032A | GSK 525768A GSK 525768A | 1260530-25-3 | 10mM * 1mLin DMSO | 3036元 |
1260530-25-3, GSK 525768A 相关搜索:
- 细胞生物学试剂
- BROMODOMAIN抑制剂(GSK 525768A)
- 化合物 T11472
- 1260530-25-3
- GSK525768A; GSK-525768A
- 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4R)-
- GSK-525768
- (4R)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide
- GSK-525768A
- GSK525768A
- GSK 525768A